(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HXP

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HXP

ST13

US500000099070320

Class

5

Filing

99070320

Registration

8003748

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

11

Latest update

10/28/2025

Trademark type

Combined

Nice classes

5

Filing date

03/06/2025

Registration date

10/28/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/28/2025

Last transaction

10/28/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

16

Owner location

Fuzhou, Fujian, CN

Examiner

WOLFE,YOUNG J

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a device and stylized wording "HXP", with the device part consisting of eight unevenly sized squares and a cross of the same size as the letter "H" on the right.

Holders and representatives

Holders

Fujian Haixi Pharmaceuticals Co., Ltd.

Representatives

Roman Campos Muncy, Geissler, Olds & Lowe PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations for the treatment and prevention of Cardiovascular and cerebrovascular system diseasesrespiratory system diseasesdigestive system diseasesneurological system diseasesendocrine system diseasesautoimmune system diseaseshematological system diseasestumorseye diseasesoral diseases; Chemical contraceptives; Bacterial preparations for medical and veterinary use; Balsamic preparations for medical purposes; Antibiotics; Antiseptics; Germicides; Analgesics; Preparations for the treatment of burns; Medicines for alleviating constipation; Antibiotic ointments; Medicinal drinks; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Injectable dermal fillers

Publications

History of USPTO decisions and trademark events.

11 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/28/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/09/2025

PUBO

PUBLISHED FOR OPPOSITION

09/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/03/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/09/2025

DOCK

ASSIGNED TO EXAMINER

08/07/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/28/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/28/2025

MAFR

APPLICATION FILING RECEIPT MAILED

03/06/2025

NWAP

NEW APPLICATION ENTERED

03/06/2025

Continuous trademark protection

Get notified about every new filing that threatens HXP or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.